3Rs Implementation in Veterinary Vaccine Batch-Release Testing: Current state-of-the-art and future opportunities

6th October 2022

Europe & Americas Webinar

The webinar aims to outline the state-of-the-art non-animal approaches for veterinary vaccines batch-release testing. It includes information on the state of the deletion of obsolete safety testing, and about the current initiatives taken so far by European, North and South America stakeholders on 3Rs implementation and regulatory acceptance.

 This webinar is part of a series of events, webinars and a face-to-face workshop, to act as a collective venue of discussion and alignment on current and future opportunities to facilitate the implementation and global regulatory alignment of new non-animal batch release testing.



Laura Viviani, AFSA
Joris Vandeputte, IABS-EU

Overview about implementation and regulatory acceptance of non-animal testing in veterinary vaccines:

Angela Walker, USDA
Laurent Mallet, EDQM
Representative from MAPA
Corinne Philippe, HealthforAnimals

Animal batch safety test: A case study on test deletion and (yet to be) global harmonization. (incl. 5 mins Q&A):

Terrie Joe Hamtak, MSD AH
Angela Walker, USDA  


Rabies in vitro potency test (incl. 5 mins Q&A):

Catrina Stirling, Zoetis (VAC2VAC)
Florence Cliquet, ANSES (France), WOAH

EDQM BSP130 – Validation of cell-based assays for in-process toxicity and antigenicity testing of Clostridium septicum vaccines (incl. 5 mins Q&A):

Botond Siklódi, Ceva

General toxicity test on Clostridials (incl. 5 mins Q&A):

Silvia Fragoeiro, MSD AH

Cl. Tetanus in vitro potency test (ELISA) (incl. 5 mins Q&A):

Paul Stickings, NIBSC (VAC2VAC)
Ann Thomas, Zoetis (VAC2VAC)

Closing remarks:

Joris Vandeputte, IABS-EU
Rick Clayton, HealthforAnimals
Laura Viviani, AFSA 


back to top